Articles related to PTSD

Discover how MDMA-assisted therapy is setting new benchmarks in PTSD treatment, offering clinically meaningful improvements and a strong safety profile.

This 22-year study provides a detailed examination of the relationship between antihypertensive medications and PTSD incidence in trauma victims. Physicians interested in the potential preventive role of these medications in PTSD are invited to delve into the findings and implications for future research.

Recent phase 3 clinical trials have demonstrated the eye-opening potential of MDMA in the treatment of PTSD when paired with psychotherapy, providing a new method of patient care.

The preliminary findings suggest a potential new direction for managing chronic pain in PTSD, inviting further research and consideration in the clinical field.

The number and quality of available studies on ketamine plus psychotherapy are limited because of the newness of the therapy. However, in the 4 studies deemed eligible for review, ketamine plus psychotherapy—regardless of protocol—was associated with significant symptom reduction.

In comparing PTSD to PTSD plus sexual abuse, minors with PTSD following sexual abuse are more likely to suffer MDD, substance use disorder, and suicidal behavior.